抗小鼠CXCL9(MIG-2F5-5)体内抗体-低内毒素
货号：ICH1204-5mg
品牌：ichorbio
产品特性
Anti-Mouse CXCL9 (MIG-2F5-5) In Vivo Antibody - Low Endotoxin is manufactured in an cGMP compliant facility.
内毒素: <1.0 EU/mg as determined by the LAL method
纯度: >95% by SDS-PAGE
应用: Flow Cytometry, Immunofluorescence, Neutralization.
| 规格 | 价格 |
|---|---|
| 5mg | ￥咨询 |
产品咨询：info@biopcr.com
产品订购：sales@biopcr.com
技术支持：tech@biopcr.com
服务热线：400-860-6200
详细介绍
产品名称：抗小鼠CXCL9(MIG-2F5-5)体内抗体-低内毒素
别名：抗小鼠CXCL9体内抗体, 抗小鼠CXCL9抗体-低内毒素, Anti-Mouse CXCL9 (MIG-2F5-5) In Vivo Antibody - Low Endotoxin, Anti-Mouse CXCL9 In Vivo Antibody, Anti-Mouse CXCL9 Antibody - Low Endotoxin,
宿主：Armenian Hamster
应用：Flow Cytometry, Immunofluorescence, Neutralization
亚型：Armenian Hamster IgG
克隆：MIG-2F5-5
浓度：≥ 2.0 mg/ml
免疫原：Mouse plasmacytoid dendritic cells
反应性：Mouse
特异性：MIG-2F5-5 activity is directed against murine CXCL9 (monokine induced by gamma interferon, MIG).
存储溶液：Sterile, preservative-free, solution in PBS. BSA and Azide free.
储存条件：This antibody is stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
推荐同型对照（Isotype Control）：Armenian Hamster IgG Isotype Control for In Vivo - Low Endotoxin [PIP] (ICH2251)
推荐缓冲液（Buffer）：体内抗体缓冲液pH5.0；体内抗体缓冲液pH7.4；体内抗体缓冲液pH8.0
靶点（Target）: CXCL9
纯化方法（Purification method）: This monoclonal antibody was purified using Protein A
抗原分布（Antigen Distribution）：CXCL9 is mainly secreted by macrophages, monocytes, endothelial cells, fibroblasts, and cancer cells in response to IFN-γ and is also expressed in intratumoral dendritic cells.
纯度（Purity）：>95% by SDS-PAGE
内毒素（Endotoxin）：<1.0 EU/mg as determined by the LAL method
聚集（Aggregation）：Aggregation level ≤ 5%
应用说明（Application Notes）：Each investigator should determine their own optimal working dilution for specific applications.
产品使用（Use）：Products are for research use only. Not for use in diagnostic or therapeutic procedures.
运输条件：Blue ice
返回列表
推荐缓冲液（Buffer）：体内抗体缓冲液pH5.0；体内抗体缓冲液pH7.4；体内抗体缓冲液pH8.0
靶点（Target）: CXCL9
纯化方法（Purification method）: This monoclonal antibody was purified using Protein A
抗原分布（Antigen Distribution）：CXCL9 is mainly secreted by macrophages, monocytes, endothelial cells, fibroblasts, and cancer cells in response to IFN-γ and is also expressed in intratumoral dendritic cells.
纯度（Purity）：>95% by SDS-PAGE
内毒素（Endotoxin）：<1.0 EU/mg as determined by the LAL method
聚集（Aggregation）：Aggregation level ≤ 5%
应用说明（Application Notes）：Each investigator should determine their own optimal working dilution for specific applications.
产品使用（Use）：Products are for research use only. Not for use in diagnostic or therapeutic procedures.
运输条件：Blue ice
